TY - JOUR
T1 - Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions
AU - Schmieder, Anne H.
AU - Caruthers, Shelton D.
AU - Keupp, Jochen
AU - Wickline, Samuel A.
AU - Lanza, Gregory M.
N1 - Publisher Copyright:
© 2015 THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company
PY - 2015/12/1
Y1 - 2015/12/1
N2 - The research roots of 19fluorine (19F) magnetic resonance imaging (MRI) date back over 35 years. Over that time span, 1H imaging flourished and was adopted worldwide with an endless array of applications and imaging approaches, making magnetic resonance an indispensable pillar of biomedical diagnostic imaging. For many years during this timeframe, 19F imaging research continued at a slow pace as the various attributes of the technique were explored. However, over the last decade and particularly the last several years, the pace and clinical relevance of 19F imaging has exploded. In part, this is due to advances in MRI instrumentation, 19F/1H coil designs, and ultrafast pulse sequence development for both preclinical and clinical scanners. These achievements, coupled with interest in the molecular imaging of anatomy and physiology, and combined with a cadre of innovative agents, have brought the concept of 19F into early clinical evaluation. In this review, we attempt to provide a slice of this rich history of research and development, with a particular focus on liquid perfluorocarbon compound-based agents.
AB - The research roots of 19fluorine (19F) magnetic resonance imaging (MRI) date back over 35 years. Over that time span, 1H imaging flourished and was adopted worldwide with an endless array of applications and imaging approaches, making magnetic resonance an indispensable pillar of biomedical diagnostic imaging. For many years during this timeframe, 19F imaging research continued at a slow pace as the various attributes of the technique were explored. However, over the last decade and particularly the last several years, the pace and clinical relevance of 19F imaging has exploded. In part, this is due to advances in MRI instrumentation, 19F/1H coil designs, and ultrafast pulse sequence development for both preclinical and clinical scanners. These achievements, coupled with interest in the molecular imaging of anatomy and physiology, and combined with a cadre of innovative agents, have brought the concept of 19F into early clinical evaluation. In this review, we attempt to provide a slice of this rich history of research and development, with a particular focus on liquid perfluorocarbon compound-based agents.
KW - angiogenesis
KW - cell labeling
KW - dual-tuned coil
KW - fluorine
KW - magnetic resonance imaging (MRI)
KW - perfluorocarbon
UR - http://www.scopus.com/inward/record.url?scp=85002722312&partnerID=8YFLogxK
U2 - 10.15302/J-ENG-2015103
DO - 10.15302/J-ENG-2015103
M3 - Review article
C2 - 27110430
AN - SCOPUS:85002722312
SN - 2095-8099
VL - 1
SP - 475
EP - 489
JO - Engineering
JF - Engineering
IS - 4
ER -